-
Catalog
E058269
-
species
Mouse
-
GeneLTF-AB-lgG
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of LTF Ab-IgG. No significant cross-reactivity or interference between LTF Ab-IgG and analogues was observed. NOTE: Limited by current skills and knowledge, it is impossible for us to complete the cross-reactivity detection between LTF Ab-IgG and all the analogues, therefore, cross reaction may still exist in some cases.
-
SamplesSerum, Plasma , tissue homogenates,Cell culture supernates,Other biological fluids.
-
Sensitivity1.0 u/mL.
-
Intended UseMouse LTF-AB-lgG ELISA Kit allows for the in vitro quantitative determination of LTF-AB-lgG , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
-
StorageFor 5-7days:Store the whole kit at 4℃
For a Long time :Store the Substrate at 4℃, other reagent should store at -20℃.
-
Product Categories/FamilyMouse ELISA Kit
-
Product Description
specificalFor Sample Serum, plasma, cell culture supernatants, body fluid and tissue homogenate INTENDED USE: This LTF Ab-IgG ELISA kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of Mouse LTF Ab-IgG. This ELISA kit for research use only, not for therapeutic or diagnostic applications!
PRINCIPLE OF THE ASSAY: LTF Ab-IgG ELISA kit applies the competitive enzyme immunoassay technique utilizing a monoclonal anti-LTF Ab-IgG antibody and an LTF Ab-IgG-HRP conjugate. The assay sample and buffer are incubated together with LTF Ab-IgG-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the LTF Ab-IgG concentration since LTF Ab-IgG from samples and LTF Ab-IgG-HRP conjugate compete for the anti-LTF Ab-IgG antibody binding site. Since the number of sites is limited, as more sites are occupied by LTF Ab-IgG from the sample, fewer sites are left to bind LTF Ab-IgG-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The LTF Ab-IgG concentration in each sample is interpolated from this standard curve.
-